These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Use of intravenous acyclovir for treatment of herpes zoster ophthalmicus in patients at risk for AIDS. Seiff SR; Margolis T; Graham SH; O'Donnell JJ Ann Ophthalmol; 1988 Dec; 20(12):480-2. PubMed ID: 3265292 [TBL] [Abstract][Full Text] [Related]
6. Increased risk of a cancer diagnosis after herpes zoster ophthalmicus: a nationwide population-based study. Ho JD; Xirasagar S; Lin HC Ophthalmology; 2011 Jun; 118(6):1076-81. PubMed ID: 21232800 [TBL] [Abstract][Full Text] [Related]
7. Herpes zoster ophthalmicus. Dawodu OA; Osahon AI; Alikah AA; Bakare CE S Afr Med J; 2005 Jan; 95(1):30-1. PubMed ID: 15762243 [No Abstract] [Full Text] [Related]
9. Posttraumatic herpes zoster ophthalmicus as a presenting sign of human immunodeficiency virus infection. Netland PA; Zierhut M; Raizman MB Ann Ophthalmol; 1993 Jan; 25(1):14-5. PubMed ID: 8427484 [TBL] [Abstract][Full Text] [Related]
10. Human immunodeficiency virus infection in a child presenting as herpes zoster ophthalmicus. Pandey N; Chandrakar AK; Adile SL; Garg ML; Patel S J Indian Med Assoc; 2007 Apr; 105(4):216-7. PubMed ID: 17822193 [TBL] [Abstract][Full Text] [Related]
11. Does herpes zoster ophthalmicus increase the risk of stroke? Nagel M; Ortiz GA Neurology; 2010 Mar; 74(10):788-9. PubMed ID: 20200347 [No Abstract] [Full Text] [Related]
12. HIV/AIDS in ophthalmic patients: The Guinness Eye Centre Onitsha experience. Nwosu NN Niger Postgrad Med J; 2008 Mar; 15(1):24-7. PubMed ID: 18408779 [TBL] [Abstract][Full Text] [Related]
13. Evaluation and management of herpes zoster ophthalmicus. Shaikh S; Ta CN Am Fam Physician; 2002 Nov; 66(9):1723-30. PubMed ID: 12449270 [TBL] [Abstract][Full Text] [Related]
14. Recognition of herpes zoster ophthalmicus. Krimmer JE Insight; 1994 Jun; 19(2):14-6. PubMed ID: 8006487 [TBL] [Abstract][Full Text] [Related]
15. Ocular opportunistic infection incidences among patients who are HIV positive compared to patients who are HIV negative. Hodge WG; Seiff SR; Margolis TP Ophthalmology; 1998 May; 105(5):895-900. PubMed ID: 9593394 [TBL] [Abstract][Full Text] [Related]
17. Herpes zoster ophthalmicus and the immunocompromised host: a case report and review. McPherson RE J Am Optom Assoc; 1997 Aug; 68(8):527-38. PubMed ID: 9279053 [TBL] [Abstract][Full Text] [Related]
18. Assessment of cytosine arabinoside in the management of herpes zoster ophthalmicus. Wellings PC Trans Ophthalmol Soc N Z; 1979; 31():64-8. PubMed ID: 316216 [No Abstract] [Full Text] [Related]
19. Preliminary results of oral BVDU treatment of herpes zoster ophthalmicus. Maudgal PC; Dralands L; Lamberts L; De Clercq E; Descamps J; Missotten L Bull Soc Belge Ophtalmol; 1981; 193():49-56. PubMed ID: 6979370 [No Abstract] [Full Text] [Related]
20. Reduction of the ocular complications of herpes zoster ophthalmicus by oral acyclovir. Cobo M Am J Med; 1988 Aug; 85(2A):90-3. PubMed ID: 3044100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]